InvestorsHub Logo
Followers 10
Posts 782
Boards Moderated 0
Alias Born 02/08/2007

Re: tony111 post# 13400

Sunday, 04/19/2015 4:37:04 PM

Sunday, April 19, 2015 4:37:04 PM

Post# of 20689
You might get #1 but you will never get #2. You really expect MYL to change course now? That's ridiculous

I am curious to see how this plays out. Enox approval caused a large % spike followed by a quick plummet. With copax approval, thus far its been a small % spike but preceded by a slow, gradual but substantial rise (mid 10's to mid 16's over 2-3 months).

Even if MYL gets a approval eventually, why wouldn't the market start ascribing a non material value to the rest of the pipeline? MNTA's achievements to date have been ground breaking, and that should count for something. Investing is a forward looking game, after all. There some non newbie biotech investors (hey jbog) who think this is as good as it gets for MNTA. We'll see if the market agrees over the next few weeks, months. Based on what has just happened though, no idea how anyone could reach that conclusion.

I will readily admit that I am quite surprised by what happened last week, and that for the first time in a long time, I am genuinely excited and optimistic about MNTA's future prospects. It's been a long, tough, painful road.